How can we treat or prevent corticosteriod-induced osteoporosis?;Cómo se puede prevenir y tratar la osteoporosis inducida por glucocorticoides

Medicina Clinica

Volumn 120, Issue 12, 2003, Pages 473-475

  Danés, Imma ^a   Bosch, Montserrat ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; COLECALCIFEROL; CORTICOSTEROID; ESTRADIOL; GLUCOCORTICOID; PREDNISOLONE; PREDNISONE; RISEDRONIC ACID; VITAMIN D;

ARTICLE; DRUG INDUCED DISEASE; FEMALE; FRACTURE; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; RHEUMATOID ARTHRITIS;

EID: 0038664227     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045522     Document Type: Article

References (21)

1. Laan RFJM, Van Riel PLCM, Van de Putte LBA, Van Erning LJTO, Van't Hof MA, Lemmens JAM. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis -a randomized, controlled study. Ann Intern Med 1993;119:963-8.
2. Compston JE. Management of bone disease in patients on long term glucocorticoid therapy. Gut 1999;44:770-2.
3. Anónimo. The use of inhaled corticosteroids in adults with asthma. Drug Ther Bull 2000;38:5-8.
4. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998;244:271-92.
5. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
6. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15: 993-1000.
7. Luengo M, Picado C, Río LD, Guanabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991;46:803-6.
8. Espallargues M, Sampietro-Colom L, Estrada MD. Osteoporosis: factores de riesgo y densitometría. Med Clin (Barc) 2002;118:319.
9. American College of Rhematology Ad Hoc Committee on Glucocortcoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2001;44: 1496-503.
10. Homik J, Suárez-Almazor ME, Shea B, Cranney A, Wells G, Tugwell P. Calcium and vitamin D for corticosteroid-induced osteopoross (Cochrane Review). En: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
11. Hall GM, Daniels M, Doyle DV, Spector TD. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 1994;37:1499-505.
12. Homik J, Cranney A, Shea B, Tugwell P, Wells G, Adachi R, et al. Bisphosphonates for seroid induced osteoporosis (Cochrane Review). En: The Cochrane Library, Issue 2, 2002. Oxford. Update Software.
13. Sebaldt RJ, Ioannidis G, Adachi JD, Bensen WG, Bianchi F, Cividino A, et al. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis. J Rheumatol 1999;26:1545-9.
14. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998;339:292-9.
15. Adachi JD, Saag K, Delmas PD, Liberman UA, Emkey RD, Seeman E, et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids. A randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 2001;44:202-11.
16. Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, et al. Risedronate therapy provents corticosteroid-induced bone loss. Arthritis Rheum 1999;42:2309-18.
17. Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S, et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European corticosteroid-induced osteoporosis treatment study. J Bone Miner Res 2000;15:1006-13.
18. Eastell R, Devogelaer JP, Peel NF, Chines AA, Bax DE, Sacco-Gibson N, et al. Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients. Osteoporos Int 2000;11:331-7.
19. Cranney A, Welch V, Adachi JD, Homik J, Shea B, Suárez-Almazor ME, et al. Calcitonin for preventing and treating corticosteroid-induced osteoporosis (Cochrane Review). En: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
20. Crandall C. Parathyroid hormone for treatment of osteoporosis. Arch Intern Med 2002;62:2297-309.
21. Voelker R. Questions about hormone therapy remain puzzling. JAMA 2002;288:2395-6.